# PharmaCyte Biotech, Inc.: Form 8-K, filed Jan 21, 2020

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2020-01-21
- Accepted by EDGAR: Jan 21, 2020, 17:15 ET
- Period: 2020-01-21
- Accession: 0001683168-20-000204
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316820000204/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316820000204/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316820000204/pharmacyte_8k.htm

Filed Jan 21, 2020.
Source: SEC EDGAR, the filing index for accession 0001683168-20-000204. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
